KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $180,957 | +7.1% | 14,772 | +27.0% | 0.00% | 0.0% |
Q3 2022 | $169,000 | -66.0% | 11,627 | -77.0% | 0.00% | -66.7% |
Q2 2022 | $497,000 | +120.9% | 50,514 | +197.5% | 0.00% | +50.0% |
Q4 2021 | $225,000 | +2400.0% | 16,982 | +2071.6% | 0.00% | – |
Q3 2019 | $9,000 | -78.6% | 782 | -58.9% | 0.00% | -100.0% |
Q2 2019 | $42,000 | – | 1,904 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
RA Capital Management | 591,070 | $4,616,000 | 0.57% |
INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
Eventide Asset Management | 98,100 | $766,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |